Archford Capital Strategies’s United Therapeutics UTHR Stock Holding History

Archford Capital Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$552K	Buy	+1,018	New	+$573K	0.06%	233
2018 Q3	–	Sell	-6	Closed	-$1K	–	679
2018 Q2	$1K	Hold	6	–	–	﹤0.01%	652
2018 Q1	$1K	Buy	+6	New	+$762	﹤0.01%	614
2017 Q2	–	Sell	-6	Closed	-$1K	–	603
2017 Q1	$1K	Hold	6	–	–	﹤0.01%	677
2016 Q4	$0	Hold	6	–	–	﹤0.01%	750
2016 Q3	$0	Hold	6	–	–	﹤0.01%	722
2016 Q2	$1K	Buy	+6	New	+$669	﹤0.01%	672
2016 Q1	–	Sell	-6	Closed	-$1K	–	582
2015 Q4	$1K	Hold	6	–	–	﹤0.01%	798
2015 Q3	$1K	Hold	6	–	–	﹤0.01%	647
2015 Q2	$1K	Hold	6	–	–	﹤0.01%	625
2015 Q1	$1.03K	Hold	6	–	–	﹤0.01%	636
2014 Q4	$1K	Hold	6	–	–	﹤0.01%	653
2014 Q3	$1K	Hold	6	–	–	﹤0.01%	650
2014 Q2	$530	Hold	6	–	–	﹤0.01%	851
2014 Q1	$564	Buy	+6	New	+$614	﹤0.01%	795

Other funds holding UTHR

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Archford Capital Strategies's UTHR Position: Q2 2026 in Review

Archford Capital Strategies opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,018 shares worth $552K. The stake represents 0.06% of the portfolio and ranks #233 among its holdings. This is a return to the name: Archford Capital Strategies previously reported a position in UTHR as recently as Q2 2018.

Archford Capital Strategies first reported a position in UTHR in Q1 2014 and has held it in 15 quarters since. 83 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Archford Capital Strategies held 1,018 shares of United Therapeutics worth $552K as of Q2 2026.
United Therapeutics was a new Archford Capital Strategies position in Q2 2026.
United Therapeutics made up 0.06% of Archford Capital Strategies's portfolio in Q2 2026, its #233 holding.
Archford Capital Strategies first reported a position in United Therapeutics in Q1 2014 and has held it in 15 quarters since.
83 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.